Friday Mar 10, 2023 is a very significant day in the history of Bankless, it marks the day we set sail into the realm of web3 fully. We are migrating off of a publishing platform (Substack) and self hosting a platform for equipping people along their Crypto Journey. As a top crypto media company with well over a quarter of a million subscribers, we are locking this down only to existing verified users prior to the launch.

A memento to remember the things you learned. In this video, we reviewed how leronlimab, a humanized monoclonal human CCR5 antibody, can be used to treat human breast cancer in a mouse model. These data indicate that leronlimab reduces breast cancer metastasis using in vitro and in vivo experiments, alongside identifying how it can be used in conjunction with current chemotherapeutics.

A special, exclusive Founders Badge for early members of the Guardian community.